News for Healthier Living

Updated Review Shows GLP-1 RAs Produce Significant Weight Loss in Adults Without Diabetes, with Newer Treatments Showing Greater Results

An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found that among currently available treatments, tirzepatide produced the greatest weight loss, while newer experimental drugs showed even larger effects.

August 31, 2026


September 1 2026

August 31 2026

August 30 2026

August 29 2026

August 28 2026

August 27 2026

August 26 2026

August 25 2026

August 24 2026

August 21 2026

August 20 2026

August 19 2026

August 18 2026